ISA推出红外线乳房影像检查系统

 
一项评估新型乳房影像系统的临床试验，将重点确定该系统用于早期癌症检查的附属效率。

这套Sentinel乳房影像系统，是由美国红外线科学集团公司（ISA）研制开发的，将再美国纽约Presbyterian医院－Cornell大学Weill医学院进行评估。研究参与人员将会按计划在超声或者乳房X线成像引导之下，接受乳房活检。这项研究将评估病理学、放射学以及乳房影像系统结果的相关性。

ISA公司副总裁Matthew Campisi指出：“我们十分高兴能够开始与Cornell大学的研究，我们相信来自Sentinel系统的研究信息，将会证明这套系统能够在对抗乳房癌的战争中发挥作用。Sentinel系统能够为乳房健康信息提供崭新的生理学资料，而这些资料不能从任何其它非创伤性检测方法中获得。”

Sentinel乳房扫描是一种无痛、无接触、非创伤性检查方法，适合任何年纪的女性。该技术是以尖端的数字红外线影像技术为基础的，同时联合应用了人工智能的高级软件。在4分钟的检查之后，即可为临床医生提供完整详细而客观的报告。

这套技术将作为附属程序，而不会替代乳房X线检查技术或者超声检查方法，或者用于确定乳房整体健康状况而单独使用。

Breast Imaging System
 
A clinical study to evaluate a new breast imaging system will focus on determining the adjunctive effectiveness of the system for early cancer detection.

The Sentinel BreastScan imaging system, developed by Infrared Sciences Corp. (ISC; Stony Brook, NY, USA), will be assessed at the New York Presbyterian Hospital-Weill Medical College of Cornell University (New York, NY, USA). Study participants will have been scheduled to undergo a breast biopsy, either by ultrasound or mammography. The study will correlate the outcomes of pathology, radiology, and the breast imaging system.

“We are pleased and excited to commence this study with Cornell, and we believe that the information obtained from the Sentinel system will prove it to be a highly effective adjunctive tool in the war against breast cancer,” noted Matthew Campisi, vice president, ISC. “The Sentinel system provides a new physiological dimension to breast health information that is not available from any other fully noninvasive testing material.”

The Sentinel BreastScan is a painless, touchless, noninvasive technique offered to women of any age. The technology is based on sophisticated digital infrared imaging that is combined with advanced software employing artificial intelligence methods. Immediately following the four-minute test, it provides the clinician with a fully-interpreted, objective report.

The technology is intended to be an adjunctive procedure and does not replace mammography or ultrasound, or stand alone as a single test that can determine overall breast health.